Developing new cancer treatments for children and adolescents
Official title: Children's Oncology Group Pediatric EarlyPhase Clinical Trial Network
Funded at Public Health Institute · NIH-10987452 · Data updated 2026-11-12
This study is looking for new and better treatments for kids and teens with cancer, and it will involve about 130 young patients each year from the US, Canada, and Australia to make sure the treatments fit their needs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Public Health Institute NIH-funded |
| Lab location | 1 site (Oakland, United States) |
| Project start | September 20, 2018 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $4,445,791 |
| NIH project number | 2UM1CA228823-06 |
| Project ID | NIH-10987452 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are children and adolescents diagnosed with cancer who are seeking novel treatment options.
✕Less likely to help
Patients with cancers that are not included in the trial protocols may not benefit from this research.
What this research studies
This research focuses on identifying and developing effective new treatments for children and adolescents with cancer. It involves clinical trials that utilize advanced techniques such as genomics, pharmacology, and imaging studies to understand how new therapies work. The trials will enroll approximately 130 young patients annually across various sites in the US, Canada, and Australia, ensuring a comprehensive approach to pediatric oncology. By integrating patient-reported outcomes, the research aims to tailor treatments to the specific needs of young patients.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted cancer treatments for children and adolescents.
How similar studies have gone: Previous research in pediatric oncology has shown success with similar early-phase clinical trial networks, indicating a promising approach.
Where this research is happening
-
Public Health Institute
Oakland, United States Active
Researchers
- Principal investigator: Fox, Elizabeth — Public Health Institute
- Study coordinator: Fox, Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.